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Tyrosine phosphorylation of the receptor for insulin-like growth
factor II is inhibited in plasma membranes from insulin-treated
rat adipocytes
Silvia CORVERA, Keith A. YAGALOFF, Robert E. WHITEHEAD and Michael P. CZECH
University of Massachusetts Medical Center, Department of Biochemistry, 55 Lake Avenue North,
Worcester, MA 01605, U.S.A.
Insulin action in intact adipocytes leads to a rapid increase in the concentration of receptors for insulin-like
growth factor (IGF) II on the adipocyte cell surface, and to a decrease in the [32P]phosphate content of these
receptors on the plasma membrane [Corvera & Czech (1985) Proc. Natl. Acad. Sci. U.S.A. 82, 7314-7318].
It has been previously shown that the receptor for IGF-II can be phosphorylated on tyrosine residues by
a kinase activity which is expressed in isolated adipocyte plasma membranes. It is now shown that IGF-II-
receptor phosphorylation in vitro, in plasma membranes derived from insulin-treated cells, is markedly
decreased compared with the phosphorylation of the receptor in membranes from control cells. This effect
of insulin cannot be attributed to an increase in the activity of phosphotyrosyl phosphatase in the
membranes. The tyrosine kinase that catalyses the phosphorylation of IGF-II receptors is associated with
a fraction of the plasma membrane which is insoluble in Triton X-100. Removal of the Triton X-100-soluble
components of the membrane markedly enhances receptor phosphorylation. Moreover, the expression of
the inhibitory effect of insulin requires the presence of one or several Triton X-100-soluble components of
the plasma membrane.
INTRODUCTION
One of the major effects of insulin on its target cells is
a rapid increase in the expression of several membrane
proteins at the cell surface. This effect involves a
redistribution of these proteins from an intracellular
membrane compartment (low-density microsomal frac-
tion) to the cell surface membrane. Three of the proteins
that are known to be affected in this manner in response
to insulin are the glucose transporter [1-3], the IGF-II
receptor [4,5] and the transferrin receptor [6].
Isotopic labelling experiments using [32P]phosphate
have shown that IGF-II receptors in plasma membranes
are phosphorylated in vivo on serine and threonine
residues, to a higher stoichiometry than the receptors
found in low-density microsomal membranes. The
redistribution of IGF-II receptors that occurs on
exposure of intact cells to insulin correlates with a rapid
decrease in the phosphoserine and phosphothreonine
contents of the receptors which reside on the plasma
membrane [7,8]. The phosphorylation of the IGF-II
receptor in isolated rat adipocyte plasma membranes
has also been studied. It has been found that, on
incubation of the membranes with [y-32P]ATP, the
receptors become phosphorylated on tyrosine residues.
This phosphorylation is catalysed by a potent tyrosine
kinase activity endogenous to the adipocyte plasma
membrane [9].
In the present paper we report that insulin treatment
of intact adipocytes results in a pronounced and rapid
inhibition of tyrosine phosphorylation of IGF-II recep-
tors in subsequently isolated plasma membranes.
MATERIALS AND METHODS
Preparation of cells and plasma membranes
Plasma membranes were prepared from isolated
adipocytes obtained from 75-100 g Sprague-Dawley rat
(Taconic Farms) epididymal fat-pads as previously
described [10]. Where indicated, cells were exposed to
0.1 #M-insulin for 10 min at 37 'C. The cell suspensions
were then centrifuged (500 g for 2 min), and the
buffer was aspirated. Cells were homogenized in 8 vol.
of a buffer containing 0.25 M-sucrose, 10 mM-Tris/
HCl, 5 mM-EDTA and 100 /tM-phenylmethanesulphonyl
fluoride, pH 7.4 at 5 'C. Plasma membranes were
separated as described previously [4,11]. Protein con-
centrations were determined by the Bradford [12] pro-
cedure (Bio-Rad).
Phosphorylation of the IGF-II receptor
(a) Intact plasma membranes (final concn. 2 mg of
protein/ml) were resuspended in a buffer (phosphoryl-
ation buffer) containing 25 mM-Hepes, 80 mM-fl-glycero-
phosphate, 10 mM-MgCl2, 2 mM-MnCl2, 100 gtM-phenyl-
methanesulphonyl fluoride and 10 mM-ammonium
molybdate (Sigma), pH 7.4 at 5 'C. Portions (50 #1) of
the membrane suspension were used for each sample.
Phosphorylation reactions were started by the addition
of 5 ,ul of a 1 mm stock of [y-32P]ATP (Amersham) to give
a final concentration of 100 puM (10 ,uCi/nmol), and
continued for 10 min at 5 "C. Reactions were terminated
by addition of 500 pl of solubilizing buffer, containing
25 mM-Hepes, 1.5% Triton X- 100, 1 % sodium deoxy-
Abbreviation used: IGF, insulin-like growth factor.
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cholate, 0.1% SDS, 1 % bovine serum albumin, 0.5 M-
NaCl, 50 mM-NaF, 100 #uM-Na3VO5, 50 mM-Na4PAO7,
S mM-EDTA and 100 ,uM-phenylmethanesulphonyl
fluoride, pH '7.4 at 5 °C.
(b) Triton X-100-solubilized plasma membranes were
prepared by vigorously vortex-mixing intact membranes
(2 mg/ml) in the phosphorylation buffer described
above, containing 1% Triton X-100 (Bio-Rad), for
30 min at 55 °C. The phosphorylation reactions were
started by the addition of [y-32P]ATP as described above.
After incubation for the times indicated in each Figure
legend, the reactions were stopped by the addition of
500 ,1 of solubilizing buffer.
(c) The experiments shown in Figs. 4 and 6 illustrate
the phosphorylation ofthe IGF-II receptor present in the
Triton X-100-insoluble membrane fractions. For these
experiments, plasma membranes were resuspended
(2 mg/ml) in phosphorylation buffer containing 1%
Triton X-100. After incubation for 30 min at 5 °C, the
suspensions were centrifuged at 5000 g for 10 min.
Supernatants were removed, and the Triton X-l00-
insoluble pellets were gently resuspended in 50,l of
phosphorylation buffer at 5 °C, with a 27k gauge needle




After the addition of solubilizing buffer, approx. 10 ,ug
of rabbit polyclonal anti-(IGF-II receptor) immuno-
globulin coupled to 20 ,ul of Affi-Gel 10 (Bio-Rad) was
added to each sample. Immunoadsorptions were per-
formed overnight at 4 °C on an end-over-end mixer. The
resin was then washed twice with solubilizing buffer and
once with 25 mM-Hepes/0.15 % Triton X-100/0.1%
SDS, pH 7.4. The samples were then boiled for 2 min in
50 mM-Tris/HCl/3 % SDS/0.005% Bromophenol Blue/
20% (v/v) glycerol, pH 6.8, and separated on a 6 %-
polyacrylamide slab gel by the Laemmli [13] method.
Gels were then stained with Coomassie Brilliant Blue,
dried and exposed to Kodak X-OMAT film at -70 'C.
Phosphoamino acid analyis
Gel slices corresponding to autoradiography bands
were excised and subjected to tryptic digestion in 0.1 M-
N-ethylmorpholine acetate, pH 8.3, for 24 h at 37 'C.
The tryptic peptides were freeze-dried to dryness,
resuspended and hydrolysed in 6 M-HCI for 75 min at
110 'C. The hydrolysates were dried, resuspended in a
solution containing phosphoserine, phosphothreonine
and phosphotyrosine (1 mg/ml each), and spotted on
thin-layer cellulose plates (Brinkman Instruments).
Electrophoresis was then performed for 120 min at
1000 V with a running buffer of acetic acid/pyridine/
water (10: 1:189, by vol.). Plates were then dried, spots
detected by ninhydrin staining, and the plates auto-
radiographed at -70 'C.
RESULTS
Fig. 1 shows the effect of brief insulin treatment of
intact adipocytes on the subsequent phosphorylation of
IGF-II receptors in plasma membranes prepared from
these cells. Triton X-100-solubilized plasma membranes
were employed because in previous experiments it was






Fig. 1. Time course of IGF-H-receptor phosphorylation in
membranes from control or insulin-treated rat adipocytes
Plasma membranes were prepared from control cells (C)
or cells treated with 0.1 uM-insulin (I) as described in the
Materials and methods section. Plasma membranes were
resuspended in phosphorylation buffer containing 1%
Triton X-100. After 30 min at 5 °C, [y-32P]ATP was
added, to a final concentration of 100 /LM. The reactions
were terminated after incubation at 5 °C for the times
indicated (5, 7.5 and 10 min), by the addition of a 10-fold
excess of solubilizing buffer as described in the Materials
and methods section. The receptor immunoprecipitates
were applied on a 6%-polyacrylamide gel. Autoradio-
graphs of such gels showed one main band at Mr
230000, which corresponds to the value for the IGF-II
receptor. Some of the radioactivity remained at the top of
the separating gel, possibly representing an aggregation
product of the solubilized immunoprecipitated receptor.
[32P]phosphate incorporated into the IGF-II receptor [9].
After addition of 100 1tM-[y-32P]ATP to the membranes,
IGF-II-receptor phosphorylation increased linearly over
a 10 min period at 5 'C. The rate at which 32P was
incorporated into IGF-II receptors was greatly decreased
in membranes derived from insulin-treated cells com-
pared with those derived from control cells.
The identities of the phosphorylated residues on the
IGF-II receptor were investigated by thin-layer electro-
phoresis of an acid hydrolysate of the protein. Fig. 2
shows that incubation of plasma membranes from
control cells with [y-32P]ATP resulted in the incorpor-
ation of [32P]phosphate into tyrosine residues. The
phosphoamino acid analysis of the receptor in mem-
branes derived from insulin-treated cells was complicated
by the very low amount of [32P]phosphate incorporated.
However, prolonged exposure of the thin-layer plates
revealed the presence of phosphotyrosine. No phospho-
serine or phosphothreonine was detected. In a previous
paper [9] and in some of the experiments described
below, it was shown that the tyrosine kinase that
phosphorylates the IGF-II receptor is tightly bound to
the Triton X-100-insoluble fraction of the plasma
membrane, and that it preferentially phosphorylates the
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Fig. 2. Phosphoamino acid analysis of the IGF-ll receptor
Intact plasma membranes from control cells (C) or cells
treated with 0.1 gM-insulin (I) were incubated with[yi32P]ATP (25 1sCi/nmol) as described in the Materials
and methods section. The IGF-II receptor was immuno-
precipitated from these membranes and phosphoamino
acid analysis was performed as described in the Materials
and methods section. The positions of the phosphoamino
acid standards [phosphoserine, Ser(P), phosphothreonine,
Thr(P) and phosphotyrosine Tyr(P)] are indicated.
Exposure of the thin layers was 12 h (C) or 72 h (I).
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Triton X-100-insoluble fractions of adipocyte plasma
membranes
Plasma membranes from control cells were isolated and
electrophoresed on a 6-16%polyacrylamide slab gel. The
left lane contains 50 ,ug of membrane protein. The middle
lane is the fraction of this preparation that is soluble in
1% Tniton X-100, and the right lane is the Tniton X-100-
insoluble matenial obtained from the same preparation.
Positions of Mr standards are indicated.
shows that a large majority of the protein found in this
preparation of adipocyte plasma membranes is soluble in
1% Triton X-100, whereas only few major proteins
compose the Triton X-100-insoluble structure. Thus the
activity of the tyrosine kinase toward the IGF-II receptor
can be studied in the presence or absence of detergent-
soluble membrane components, which might potentially
regulate the phosphorylation reaction.
The results shown in Fig. 4 compare the magnitude of
32p incorporation into IGF-II receptors when the
phosphorylation reaction was performed with (1) intact
plasma membranes, (2) Triton X-100-solubilized plasma
membranes, (3) the Triton X-100-insoluble fraction of
the plasma membrane and (4) the Triton X-100-soluble
fraction of the plasma membrane, all derived from
control or insulin-treated cells. Several important findings
were observed. First, as described previously [9], addition
of Triton X-100 to the plasma membranes dramatically
increased the incorporation of 32p into the IGF-II
receptor (exposure times are indicated in the legend to
Fig. 4).
Second, the effect ofinsulin to inhibit 32p incorporation
into IGF-II receptors was most pronounced when the
phosphorylation reaction was carried out with intact
plasma membranes. On solubilization of the membranes
in Triton X-100, the inhibitory effect persisted, but was
less pronounced than that observed in intact membranes.
However, when the Triton X-100-soluble components
were removed from the insoluble fraction before initia-
tion of the phosphorylation reaction, the inhibitory effect
of insulin was completely abolished. Under these
conditions the amount of 32P associated with the receptor
band was actually increased in the receptors obtained
from insulin-treated cells compared with controls. This
effect could be accounted for by the increased number of
receptors that exist in plasma membranes derived from
insulin-treated cells [4,5]. Taken together, these results
strongly suggest that the inhibition of 32p incorporation
into IGF-II receptors observed in membranes from
insulin-treated cells is conferred by a component of the
plasma membrane which is soluble in Triton X-100.
Another observation made in this experiment is that
32p incorporation into the receptors present in the Triton
X-100-soluble fraction of the plasma membrane could
not be observed, neither when [32P]ATP was added to the
soluble portion after it was separated from the insoluble
structure (Fig. 4) nor when the [y-32P]ATP was added
before separation of the fractions (results not shown).
These results confirm that only the receptors present in
the Triton-insoluble structure can become tyrosine-
phosphorylated under the conditions of these experi-
ments, perhaps reflecting a strict steric requirement for
this reaction to occur. Analysis of the binding of 12511
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Fig. 4. Phosphorylation of the IGF-II receptor in membranes
from control and insulin-treated cells
The phosphorylation of the IGF-II receptor was studied in
intact membranes (intact), in membranes resuspended in
buffer containing 1% Triton X-100 (+ 1% Triton), in the
Triton X-100-insoluble fraction of the membrane (Triton-
insoluble), or in the Triton X-100-soluble fraction of the
membrane (Triton soluble), all obtained from control (C)
or insulin-treated (I) adipocytes. The phosphorylation
buffer and the methods employed to obtain the different
membrane fractions are described in the Materials and
methods section. Phosphorylation reactions were started
with 100 ,#M-[y-32P]ATP, and continued for 10 min at
5 'C. The IGF-II receptor was then immunoprecipitated,
separated on a 6 %-polyacrylamide slab gel, and detected
by autoradiography. The exposure time for the experiment
carried out in intact plasma membranes was 72 h; for the
rest of the experiments it was 20 h. Exposure of the gels for
up to 5 days did not reveal 32P incorporation into receptors
obtained from the Triton X-100-soluble membrane
fraction. Similar results were obtained in five successive
experiments, with different cell preparations.
Fig. 5. Use of unlabelled ATP chase for detection of IGF-II-
receptor phosphatase activity
Plasma membranes were obtained from control (Control)
or insulin-treated cells (Insulin) and resuspended in
phosphorylation buffer containing 1% Triton X-100.
Phosphorylation reactions were started with 100 4uM-
[y-32P]ATP and continued for 10 min. Where indicated
(+), unlabelled ATP was then added (final concn. 2 mM).
After 10 min of further incubation, the reactions were
stopped and the IGF-II receptor was immunoprecipitated,
electrophoresed and detected by autoradiography.
the total number of receptors in the plasma membrane
were contained in the Triton-insoluble structure (results
not shown).
The possibility that the Triton X-100-soluble com-
ponent that mediates that inhibitory effect of insulin
could be a phosphotyrosyl phosphatase activity was
investigated. An experiment was performed in which a
10-fold excess of unlabelled ATP was added after
incubation of the membranes with [32P]ATP. The activity
of a receptor phosphotyrosyl phosphatase would be
reflected, under these conditions, by a decrease in the
amount of 32P in the receptor. The results of this
experiment (Fig. 5) show that incubation of the mem-
branes with unlabelled ATP for 10 min resulted in a
small decrease in the amount of 32P in the IGF-II
receptor, demonstrating the presence ofa phosphotyrosyl
phosphatase activity. However, the decrease was small,
and no difference could be observed between membranes
from control or insulin-treated cells. These results do not
support the hypothesis that activation ofa phosphotyrosyl
phosphatase is responsible for the inhibitory effect of
insulin. However, the possibility remains that the
addition of a high concentration of ATP could cause a
competitive inhibition of the enzyme [14] or alter the
activities of other kinases or phosphatases that could
be involved in the modulation of IGF-II-receptor
phosphorylation. For this reason, a different experiment
was performed in which Triton X-100-insoluble mem-
brane fractions containing 32P-labelled IGF-II receptor
were used as substrates to measure the phosphotyrosyl
phosphatase activity of the Triton X-100-soluble mem-
brane extracts from control or insulin-treated cells. No
phosphatase activity could be observed on incubation of
the 32P-labelled receptors with the Triton X-100-soluble
extracts from either control or insulin-treated cell
membranes (Fig. 6). These results are consistent with
those obtained by using an excess of unlabelled ATP to
detect the presence of phosphotyrosyl phosphatase
activity (Fig. 5), and suggest that under these conditions
the activity of receptor phosphotyrosyl phosphatases is
negligible.
It is important to note that all the experiments
described above were performed in the presence of
80 mM-,f-glycerophosphate and 10 mM-molybdate.
Among several inhibitors tested (fluoride, zinc, ,-glycero-
phosphate, vanadate and molybdate), these two were
the most effective in promoting 32p incorporation into
the IGF-II receptor.
It was decided to investigate the effect of these
phosphatase-inhibitory agents on the effect of insulin to
inhibit IGF-II-receptor phosphorylation in isolated
membranes. The results shown in Fig. 7 compare the
effects of molybdate, vanadate and fluoride on the
phosphorylation of the IGF-II receptor in membranes
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Fig. 6. Assay for the presence of IGF-ll-receptor phosphatase
activity in Triton X-100-soluble extracts of adipocyte
plasma membranes
The Triton X-100-insoluble fraction of the plasma
membrane was obtained from control cells as described in
the Materials and methods section, and incubated in
phosphorylation buffer with 100 /tM-[y-32P]ATP for
10 min. The suspension was then centrifuged for 10 min
and the supernatant was removed. The detergent-insoluble
pellets were gently resuspended in 50 ,ul of phosphorylation
buffer (+) containing 1 % Triton X-100 or in 50,u1 of
Triton X-100-soluble extracts derived from plasma
membranes obtained from control (C) or insulin-treated
(I) cells. The suspensions were incubated for the time
indicated above each lane, after which the IGF-II receptor
was solubilized, immunoprecipitated, electrophoresed and
detected by autoradiography.
vanadate is almost as effective as molybdate in promoting
the basal incorporation of [32P]phosphate into the
receptor. Fluoride, a selective phosphoseryl phosphatase
inhibitor, is much less effective in promoting IGF-II-
receptor phosphorylation. Interestingly, whereas the de-
crease in IGF-II-receptor phosphorylation in membranes
from insulin-treated cells persisted in the presence of
vanadate, it became undetectable when fluoride was
employed. Fluoride is known to have multiple effects on
membrane components, such as the stimulation of
adenylate cyclase activity [15] and of photoreceptor
phosphodiesterase [16], through its interaction with
GTP-binding proteins [16]. However, an intriguing
possibility is that fluoride could block the effect of insulin
on tyrosine phosphorylation of the IGF-II receptor
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Fig. 7. Effect of different phosphatase inhibitors on IGF-II-
receptor phosphorylation
Plasma membranes were obtained from control (C) or
insulin-treated (I) cells and resuspended in phosphoryl-
ation buffer containing 1% Triton X-100 from which the
ammonium molybdate was omitted. After 30 min of
incubation, ammonium molybdate (MoO3), sodium
vanadate (Na3VO5) or sodium fluoride (NaF) was added
(final concn. 10 mm, 100 ,UM and 50 mm respectively).
Phosphorylation reactions were then started with [y-
32P]ATP and continued for 10 min. The IGF-II receptor was
then immunoprecipitated, electrophoresed and detected
by autoradiography.
by inhibiting an insulin-sensitive phosphoserine
phosphatase, which might in turn modulate the activity
of the tyrosine kinase.
DISCUSSION
It has previously been shown that the receptor for
IGF-II is phosphorylated in intact cells on serine and
threonine residues [7,8]. In contrast, when isolated fat-
cell plasma membranes are incubated with [y-32P]ATP,
the phosphorylation occurs principally on tyrosine
residues on the receptor [9]. This phosphorylation
reaction appears to be catalysed by a potent tyrosine
kinase activity, which is tightly bound to the Triton X-
100-insoluble portion of this membrane, and not from
an autophosphorylation reaction [9]. Interestingly, the
Triton X-100-insoluble fraction of several other cell
types has been found to contain elevated tyrosine kinase
activity [17-19], although phosphorylation of proteins
on tyrosine residues occurs rarely in these cells. These
findings suggest that the steady-state extent of tyrosine
phosphorylation is greatly suppressed in intact cells, and
is increased only under particular physiological circum-
stances or in response to specific stimuli.
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Interestingly, removal of Triton X-100-soluble com-
ponents of the plasma membrane greatly enhances the
phosphorylation of the IGF-II receptor on tyrosine
residues. Fig. 4 shows that phosphorylation of the
receptor occurs to a much lesser extent in intact
membranes than in Triton X-100-solubilized membranes.
Separation of the Triton X-100-soluble components
from the insoluble fraction enhances phosphorylation to
an even greater extent.
A key finding in this paper is that tyrosine
phosphorylation of the IGF-II receptor is dramatically
inhibited in membranes derived from insulin-treated
cells. The inhibitory effect of insulin cannot be observed
when the Triton X-100-soluble proteins are removed
from the insoluble material before the phosphorylation
reaction (Fig. 4). Therefore, the effect of insulin can be
due to an enhancement of the inhibitory interaction
between one or more membrane components which are
solubilized by the detergent, and the tyrosine kinase
present in the non-soluble material.
Such an inhibitory component could be an insulin-
sensitive phosphotyrosyl phosphatase. Removal of the
detergent-soluble phosphatase would therefore eliminate
the inhibitory effect of insulin. This possibility, however,
is not supported by the experiments that have been
performed. First, well-known phosphotyrosyl phospha-
tase inhibitors such as vanadate do not suppress the
inhibitory effect of insulin (Fig. 7). Second, incubation of
phosphorylated IGF-II receptors with unlabelled ATP
(Fig. 5) or Triton X-100 extracts from control or insulin-
treated membranes (Fig. 6) does not result in a marked
dephosphorylation of the receptor, suggesting that IGF-
1I-receptor phosphotyrosine phosphatases are not active
under the experimental conditions used.
An alternative possibility is that the effect of insulin
may be indirectly mediated through the activation of a
phosphoseryl/phosphothreonyl phosphatase. This possi-
bility is raised by the finding that fluoride, which is a
relatively selective inhibitor of such phosphatases, is
the only compound which can completely suppress
the inhibitory effect of insulin on IGF-II-receptor
phosphorylation. Moreover, we have found that in intact
cells, labelled with [32P]phosphate, insulin decreases the
phosphorylation of the receptor on threonine and serine
residues [7,8], suggesting that insulin may stimulate
the activity of a phosphoseryl/phosphothreonyl
phosphatase.
The physiological relevance of tyrosine phosphoryl-
ation of the IGF-II receptor is not known. However, it is
interesting that both the phosphorylation of the receptor
in vivo on serine and threonine residues, and the
phosphorylation in vitro on tyrosine residues, are
decreased in response to insulin. These results raise the
possibility that similar mechanisms might be involved in
mediating these effects. The enzymes involved in the
phosphorylation of the receptor may be modulated in
similar ways by insulin-sensitive kinases or phosphatases,
or by the presence of stimulatory or inhibitory factors.
The nature of the serine, threonine and tyrosine kinases
that phosphorylate the IGF-II receptor, and of the
insulin-sensitive components of the Triton X-l00-soluble
fraction, is at present unknown.
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